Skip to content
★ Sign in to follow
Insider activity · 24 months3 buys0 salesCumulative net flow
Total declarations
3
Company
1
▲ Purchases (3 ops.)
€43k
▼ Sales (0 ops.)
—

Latest filing published 06 Nov 2026 for Indoco Remedies Limited, €9,458.

Filing timeline

BuySale
Suresh G Kare

Insider track record

Disclosed buys
3
Disclosed sells
0
Signal history

Closed purchases

Market purchases
3

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 09 Sept 2026 · 60 days ago · €31k
    -16.1%
    Entry ₹254.25 · Close 04 Nov 2026 ₹213.43

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Suresh G Kare: trading record in brief

This profile gathers the share dealings of Suresh G Kare in Indoco Remedies Limited. We count 3 filings; the first trade dates from 9 September 2026 and the latest from 6 November 2026.

The open-market record is one-sided, with 3 purchases worth €43k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

In size, the median ticket on the buying side is €9,458.

The newest entry dates from 6 November 2026: an open-market purchase of €9,458, in Indoco Remedies Limited. Half of the filings or more reach the SEBI (PIT + SAST) feed on the day of the trade. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Suresh G Kare

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ▲
    Promoter and DirectorExecutivesIndoco Remedies Limited
    993,335 INR37SEBI
    4,570 shares@ ₹217.400.0050% mcap23.3% of flowEquityMarket PurchaseSEBI:a9101d44cc6dedca9c1c73841981817afa1272b1
    Canonical exit: 4 Feb 2027 (T+90)
  • ▲
    Promoter and DirectorExecutivesIndoco Remedies Limited
    284,248 INR0SEBI
    1,335 shares@ ₹212.90EquityMarket PurchaseSEBI:7bf823c1947c6d42f060185f5f63d0abee1394b6
    Canonical exit: 4 Feb 2027 (T+90)
  • ▲
    Promoter and DirectorExecutivesIndoco Remedies Limited
    3M INR43SEBI
    14,534 shares@ ₹237.900.016% mcap100.0% of flowEquityMarket PurchaseSEBI:3f0185aae028a2660421a3b17985dfa04ebdd7ed
    Canonical exit: 8 Dec 2026 (T+90)

3 of 3 declarations